A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mouse models however, D2-ags have been shown to cause a shift of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tejada, Miguel Á., Santos-Llamas, Ana I., Fernández-Ramírez, María José, Tarín, Juan J., Cano, Antonio, Gómez, Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001569/
https://www.ncbi.nlm.nih.gov/pubmed/33800198
http://dx.doi.org/10.3390/biomedicines9030269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001569/
https://www.ncbi.nlm.nih.gov/pubmed/33800198
http://dx.doi.org/10.3390/biomedicines9030269

Ejemplares similares